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ABSTRACT 
 
Pleurotus sajor-caju (oyster mushroom, PSC) is widely used 
in culinary due to its various benefits on human health. However, no 
study has been reported on its immunomodulating properties. 
Cultivated mushroom powder was used for hot aqueous extraction 
using Soxhlet technique. The PSC extract was suspended into CMC 
and prepared into 3 groups: 0.2 g/kg, 1g/kg and 2g/kg. Balb/c mice 
were orally fed daily for 21 consecutive days. Treatment of mice with 
various concentrations of PSC showed increased populations of 
CD3+/CD4+, CD3+/CD8+, CD14+ and CD 19+ cells. Interestingly, PSC-
treated mice demonstrated significant increase in CD3+/CD4+ and 
CD19+ cells. Most importantly, mice treated with PSC showed 
improved CD4+/CD8+ ratio; which indicated potential 
immunostimulating activity by PSC. In addition, no physical changes 
and signs of mortality could be detected from PSC-treated mice. The 
results suggest that PSC may improve general immune status when 
consumed consistently as a daily food option.  
 
INTRODUCTION 
 
Immunomodulation and its prospect towards human’s health exist since ancient times. Their exact 
roles in efficacy were scarcely understood despite widely practiced. Compounds such as proteins, peptides, 
and polysaccharides are commonly identified in immunomodulators and their response towards the 
immune system is essential either in up-regulating or down-regulating specific aspects of the host 
response [1]. Basically, these immunomodulators enhance body’s natural resistance against infection [2]. 
The activity of immunomodulator is not only to boost immune cells but also to normalize them when the 
immune system is highly activated. Thus, it serves as an agent to maintain and regulate the existing 
balance of system [1,3]. These activities are executed mainly via phagocytosis stimulation, lymphoid cells 
stimulation, and cellular immune function enhancement [4]. Therefore, plants and herbs as natural 
immunomodulators have been gaining great priority in keeping health in check as well as to improve the 
immune system. Recently, many advances have been made towards understanding common culinary 
plants used in daily dietary and their high claimed medicinal values towards various diseases and ailments 
[5].   
 
Mushrooms have a long history as a food source traditionally and also scientifically acclaimed for 
its medicinal properties.  Mushrooms are considered healthy foods as they are low in calories, fats, 
essential fatty acids, and high in vegetable proteins, vitamin and minerals [6,7,8,9]. In addition, mushrooms 
possessed various medicinal benefits i.e. anti-bacterial, anti-viral [10]. anti-cancer [11]. reduce cholesterol 
level [12] and also immunomodulating effects [13, 14].  
 
Grey oyster mushroom or scientifically known as Pleurotus sajor caju (PSC) is an edible mushroom 
commonly found in tropical regions. This edible mushroom is presumed to possess considerable 
 e-ISSN: 2320-1215 
p-ISSN: 2322-0112 
RRJPPS | Volume 3 | Issue 3 | July - September, 2014                           28 
importance in the human diet as they are rich in non-starchy carbohydrates, dietary fibre, β-glucans, 
minerals and vitamin-B and is low in fat content.[15] Due to these nutritional values, PSC has been 
commercially grown to meet high demands especially from food and nutraceutical industries.[16] Apart of 
the nutritional values, this PSC also possessed various significant medicinal properties . Recent studies 
showed that PSC possessed antioxidant and anti-cancer properties [17] and has a potential in modulating 
the immune system.[18] However, to date no such studies have been conducted on the immunomodulatory 
properties of this mushroom in in vitro animal models. The present study investigated the 
immunomodulatory effect of hot aqueous extract of grey oyster mushroom or PSC, a mushroom commonly 
available in Malaysia by assessing their effects on lymphocyte subpopulations and cytokines level in 
Balb/c mice.   
 
MATERIALS AND METHODS 
 
Chemicals 
 
In the present study, the following reagents were used: RPMI 1650 medium was purchased from 
Sigma chemical Co. (USA); carboxyl methyl celulose (CMC) was purchased from Sigma chemical Co. (USA); 
phosphate buffer saline, PBS (Amresco, USA); surface marker antibodies PerCP CD3, FITC CD4, PE CD8, 
FITC CD14 and FITC CD 19 were purchased from BD PharmingenTM(USA). 
 
Preparation of PSC extract 
 
Cultivated dried mushrooms were obtained from National Kenaf and Tobacco Board of Malaysia. 
The mushrooms were ground and the powder was extracted with hot water using percolation and Soxhlet 
techniques. The extracted solution was then freeze-dried into lyophilized powder form. The freeze-dried 
extract was then suspended into CMC (0.5% viscosity) and prepared into 3 different concentrations i.e. 0.2 
g/kg, 1g/kg and 2g/kg. 
 
Animals and experiment design 
 
Male Balb/c mice (age 6-8 weeks; 20-25g weight) were use in this experiment. The mice were 
housed in polystyrene cages in an air-controlled room. All animals were maintained at animal house and 
tap water was given ad libitum. The animals were acclimatized for 1 week prior to experiment. The mice 
were divided into 5 groups i.e.  Untreated (control group); CMC solution at 0.3 ml/mice daily dose (vehicle), 
0.2g/kg PSC, 1g/kg PSC and 2g/kg PSC. Animals were orally fed using gavage daily for 21 days. Pre- and 
post-treatment serum was collected from all mice groups during the experiment duration.  
 
Organ and body weight 
 
Both pre- and post-treatment body weights of animals were recorded. At the end of the study, the 
mice were sacrificed by cervical dislocation. The spleens were removed, weighed, and placed in sterile 
15ml centrifuge tubes of 1 ml RPMI-1640 medium then stored at 4°C for further analyses.  
 
Preparation of single cell suspension 
 
Each spleen was placed on a sterile culture plates and crushed by compressing between two 
sterile glass slides. Then the homogenized suspension was collected from the tissue plates and filtered 
though cell strainer 70 µm (BD Falcon™) into a new sterile centrifuge tube. The tubes were centrifuged at 
1500 rpm for 5 min at 10°C. The supernatant was discarded, and the pellet was resuspended with 1 ml of 
PBS. Cell counting was performed using hematocytometer and a total of 5×105 cell was prepared and 
aliquoted into 100µl of RPMI in a flow cytometry round-bottom tubes.  
 
Splenic T lymphocyte subsets assay by flow cytometry 
 
Splenocytes were stained by respective surface marker antibodies namely PerCP CD3+, FITC CD4+, 
PE CD8+, FITC CD14+ and FITC CD19+.  After staining process, samples were incubated in the dark area for 
20 minutes at 4°C. Later, the samples were suspended with 1ml PBS, mixed and centrifuged again. After 
carefully aspirating supernatant out, the stained cells were resuspended with 500 µl RPMI and the cells 
were stored at 4°C, overnight in the dark.  Samples were then analyzed using FACSCantoTM flow cytometry 
to identify lymphocyte cell subsets distribution.  
 
 e-ISSN: 2320-1215 
p-ISSN: 2322-0112 
RRJPPS | Volume 3 | Issue 3 | July - September, 2014                           29 
Statistical analysis 
 
Data are represented as means ± SD of each mouse from different groups. The experiments were 
carried out in triplicates. Statistical analysis was carried out using Wilcoxon W test and Mann Whitney U 
test by statistical program for social science (SPSS) version 20.0. Differences were considered as 
statistically significant when the p values were below 0.05 (p<0.05).  
 
RESULTS 
 
Effects of PSC extract on body weight  
 
Daily oral administration of PSC extract for 21 days did not result in any mortality. No signs of 
toxicity were observed as demonstrated by changes in the terminal body weights as well as the body 
weights monitored pre- and post-treatments (Figure 1).  Analysis on mice pre-and post treatment body 
weights shows PSC has no significant differences, thus exhibits less influence on the body weight.  
 
Effects of PSC extract on cell subsets distribution 
 
The mice administered with PSC extract showed increased lymphocyte subsets percentage 
(CD3+/CD4+, CD3+/CD8+, CD19+ and CD14+) after administration with various concentrations of PSC 
extract (Figure 2 a-d).  The results demonstrated significant increased of CD3+/CD4+ and CD19+ cell 
subsets when comparison made to untreated group. The PSC-treated mice also showed increased 
CD3+/CD8+ and CD14+ even though the percentage of increment was not significant. Interestingly, 
populations of CD3+/CD4+, CD3+/CD8+, CD19+ and CD14+ in treated mice showed the highest subset 
populations when administered with 0.2g/kg of PSC extract. Most importantly, the PSC-treated groups 
showed significant increased in the ratio of CD4+/CD8+ cells (Table 1).  
 
Table 1: Effects of PSC on the percentage ratio of splenic T lymphocyte subpopulations. Values represented the mean 
± SD, which were analyzed by Wilcoxon W test and Mann Whitney U test to evaluate the difference between PSC 
groups and untreated group. 
 
Group % CD4 % CD8 CD4/CD8 ratio 
Control 4.82 ± 0.72 8.60 ± 0.87 0.56 
CMC 3.13 ± 0.55 9.88 ± 1.14 0.32 
0.2g/kg 18.00 ± 2.83 11.90 ± 1.87 1.52 
1g/kg 15.85 ± 2.22 8.88 ± 1.53 1.78 
2g/kg 9.33 ± 0.51 8.14 ± 0.65 1.15 
 
Figure 1: Effect of PSC extract on mice pre- and post-body weight after orally administered with PSC extract for 
consecutive 21 days.  Values represented the mean ± SD, which were analyzed by Wilcoxon W test and Mann Whitney 
U test to evaluate the difference between PSC groups and untreated group. *p< 0.05 versus control. 
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Figure 2: FACS analysis of (a) CD3+ CD4+ helper T cell (b) CD3+ CD8+ cytotoxic T cells (c) CD19+ B cells and (d) CD14+ 
macrophages/monocytes percentages on lymphocyte cells of splenocyte populations in all mice group after 21 days 
oral administration with PSC extract. Values represented the mean ± SD, which were analyzed by Wilcoxon W test and 
Mann Whitney U test to evaluate the difference between PSC groups and untreated group. *p< 0.05 versus control. 
**p< 0.01 versus control. 
 
DISCUSSION 
 
Edible mushrooms which are usually used in culinary or alternative medicine may have important 
effects on health or even in treating diseases. Previous studies showed that many species of edible 
mushrooms have exhibited immunomodulatory activities [19]. This may be due to the presence of numerous 
fungal compounds such as polysaccharides (mostly β- and some α-glucans), proteoglycans, and proteins 
which have been extensively reported for their immunomodulatory potency and activity [1].  Recently, much 
attention has been paid to dietary components for multiple physiological activities. Grey oyster mushroom 
or PSC is widely cultivated and consumed in Malaysia due to its flavorful taste and nutritional properties 
[16]. Previous studies showed significant multiple effects of PSC to treat various diseases [11,13,14,10].  
However, to date, no specific studies reported on the immunological effect of PSC. The importance of 
disclosing its immunological properties will initiate various new applications, including value-added foods 
or nutritional supplements.  
 
In the present work, we studied the effect of oral administration of aqueous extract of PSC in an in 
vivo model. Oral administration of PSC showed that Balb/c mice treated with PSC extract showed 
significant increase of certain lymphocyte subpopulations. The importance of the percentage and ratio of T 
helper cells (CD4+) and cytotoxic T cells (CD8+) populations have become important in determining the 
balance state of immunomodulation and response to the homeostasis of intrinsic immune system [20]. 
Previous studies have shown that some food sources for examples peptides from bovine, soybean and 
whey proteins possess immune-stimulating capacity by increasing the percentage of CD4+ cells or 
CD4+/CD8+ ratio [21, 22, 23]. Flow cytometric analysis of splenocytes with CD3+/CD4+ antibodies in this study 
showed significant increase of T helper cells population in all treated groups compared to the control 
groups (Figure 2a). However, no significant increase in CD3+/CD8+ cells population could be observed from 
PSC-treated mice; even though mice treated with 0.2g/kg and 1g/kg of PSC extract demonstrated higher 
cytotoxic T cells population when compared to the control groups (Figure 2b). The finding corresponded 
with Rubel et al. where the animals treated with Ganoderma lucidum reported a selective decrease in the 
population of CD3+ and CD8+ in spleen cells [24]. Most importantly, this study demonstrated significant 
increased CD4+/CD8+ cells in all PSC-treated groups.  
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The fungal cell wall of mushroom is known to comprise chitin, β-glucans and mannan-containing 
glycoproteins [25] β-glucan, a common polysaccharide in mushrooms have been described as a potent 
immunomodulator with specific activity for T cells and antigen-presenting cells such as monocytes and 
macrophages [1]. Macrophages, dendritic cells (DCs) and B lymphocytes are the principal cell types involved 
in the presentation of exogenous antigens to CD4+ T lymphocytes. All these cells express receptors i.e. 
surface immunoglobulins (slg) in B cells [26], and Fc receptors (FcRs) [27] as well as different mannose 
receptors (MRs) in macrophages and dendritic cells [28, 29] that mediate the uptake of antigens [30] allowing 
presentation of the antigens. The results obtained in this study demonstrated PSC-treated mice produced 
significantly higher B cells population. However, CD14+ cells which predominantly expressed by 
macrophages and also DCs found to be expressed slightly higher in PSC-treated mice. Previous studies 
showed that β-glucan also stimulated the proliferation of monocytes and macrophages and have potent 
hematopoietic activities [31,32]. Shibata et al. reported that β-glucan involved in alteration of macrophage 
morphology and increased the phosphatase activity and lipopolysaccharide (LPS) stimulated NO production 
[33].  Recent evidences also suggest that mushrooms or the β-glucan modulates the production of pro-
inflammatory cytokines [24,34,35].  
 
In conclusion, the present study has demonstrated that PSC has the potential to non-specifically 
enhanced the humoral and cellular components of the host immune systems. Moreover, the positive 
immunomodulation by PSC is most likely attributed to the stimulation of helper T cells; as indicated by 
increasing ratio of CD4+/CD8+ cells. Also, there is notable pattern of declining percentage rate of 
lymphocytes subpopulations as the treatment dosage increases which may explain optimum dosage and 
its efficacy. Therefore, PSC may potentially improve general immune function when consumed in optimal 
portion and regularly as a daily food options.  
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